3 No-Brainer Stocks to Buy With $100 Right Now [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Since the green flag waved in January 2020, all three major stock indexes have oscillated between bear and bull markets on a couple of occasions. However, the Dow Jones Industrial Average S&P 500 , and Nasdaq Composite have a lengthy track record of putting stock market corrections firmly in the back seat and heading higher over the long term. This practical guarantee means anytime can be the ideal time to invest. What's great about putting your money to work on Wall Street is that most online brokerages have completely done away with minimum deposit requirements and commission fees for common stock trades on major U.S. exchanges. For everyday investors, it means any amount of money -- even $100 -- can be the perfect amount to put to work in the stock market. If you have $100 that's ready to invest, and this is cash you're absolutely certain isn't going to be needed to pay bills or cover emergencies as they arise, the following three stocks stand out as no-brainer buys right now
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer [Yahoo! Finance]Yahoo! Finance
- FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical CancerBusiness Wire
- Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1? [Seeking Alpha]Seeking Alpha
- J&J, Bristol Myers lose challenges to US drug price negotiation program [Reuters]Reuters
- UPDATE 1-US FDA grants full approval for Pfizer's cervical cancer drug [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 4/29/24 - Form 8-K
- 4/26/24 - Form 4
- 4/26/24 - Form 4
- PFE's page on the SEC website